supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago
Research Papers that Mention the Interaction
“Moreover, the introduction of non-calcium-based phosphate binders sevelamer and lanthanum carbonate) and cinacalcet (an allosteric activator of the calcium receptor that reduces PTH and the serum calciumxphosphate product) may reduce the risk of hypercalcemia with vitamin D therapy.”
Vitamin D analogs for secondary hyperparathyroidism: What does the future hold?“Randomization to sevelamer carbonate was associated with a 0.5 ng/mL (95% CI -0.9, -0.1) and 11.8 pg/ng (95% CI -20, -3.5) reduction in 24,25(OH)2D3 and VMR, respectively.”
“The proportions of patients using active vitamin D and sevelamer decreased by 6% and 20% respectively.”
“Patients treated with sevelamer received higher doses of vitamin D than those treated with CaCO3.”
“Fifty-nine respondents (44.4%) believed that sevelamer plus vitamin D was better to control PTH than calcium-based phosphate binder plus vitamin D, while 51 (38.3%) had no idea about this issue.”
“ Sevelamer is known to reduce absorption of vitamin D , E, K, and folic acid.”
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback